Reckitt Benckiser Faces Class Action Lawsuit Over Alleged Misleading Statements

ClaimsFiler reminds investors to file lead plaintiff applications in a securities class action lawsuit against Reckitt Benckiser Group PLC by August 4, 2025. The case alleges that the company failed to disclose material information during the class period, violating federal securities laws. The lawsuit claims that preterm infants were at an increased risk of developing necrotizing enterocolitis by consuming the company's Enfamil formula. Investors with losses in excess of $100,000 are encouraged to contact ClaimsFiler for more information.

Investors in Reckitt Benckiser Group plc (OTCQX: RBGLY) are being reminded to file lead plaintiff applications in a securities class action lawsuit by August 4, 2025. The lawsuit alleges that the company violated federal securities laws by failing to disclose material information during the class period, which ran from January 13, 2021, to July 28, 2024 [1][2].

The complaint, filed by Bronstein, Gewirtz & Grossman, LLC, alleges that Reckitt Benckiser Group plc made materially false and misleading statements regarding its business, operations, and prospects. Specifically, the lawsuit claims that the company did not disclose that preterm infants were at an increased risk of developing necrotizing enterocolitis (NEC) by consuming its cow's milk-based formula, Enfamil, and that this information could have a significant impact on the company's sales and legal exposure [1][2].

Investors who suffered losses in excess of $100,000 during the class period are encouraged to contact ClaimsFiler for more information. The firm is reminding investors that there is no cost to participate in the class action, and that the ability to share in any recovery does not require that they serve as lead plaintiffs [1][2].

Levi & Korsinsky, LLP, another firm representing investors in the case, has also issued a notice urging investors to file lead plaintiff applications by the August 4 deadline. The firm has a track record of securing hundreds of millions of dollars for aggrieved shareholders and has been ranked among the top securities litigation firms in the United States [1].

Investors should review the complaint and contact the firms for more information. The deadline to file lead plaintiff applications is August 4, 2025.

References:

[1] https://www.globenewswire.com/news-release/2025/07/25/3122009/3080/en/Reckitt-Benckiser-Group-plc-Class-Action-Levi-Korsinsky-Reminds-Reckitt-Benckiser-Group-plc-Investors-of-the-Pending-Class-Action-Lawsuit-with-a-Lead-Plaintiff-Deadline-of-August-4.html

[2] https://www.globenewswire.com/news-release/2025/07/25/3121989/9788/en/RBGLY-INVESTOR-ALERT-Bronstein-Gewirtz-Grossman-LLC-Announces-that-Reckitt-Benckiser-Group-PLC-Investors-with-Substantial-Losses-Have-Opportunity-to-Lead-Class-Action-Lawsuit.html